-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Women with antiphospholipid syndrome (APS) are at increased risk of thrombosis and pregnancy complications, such as recurrent early miscarriage and hypertensive disorders during pregnancy
Patient's pregnancy history:
Case study: A 35-year-old pregnant woman (4th gestation, 1st pregnancy) with SLE, lupus nephritis, and APS presents at 6 weeks of gestation (GW
Changes in blood pressure and blood sampling data:
This case of refractory APS with SLE was successfully treated with HCQ, LDA, therapeutic doses of UFH, prednisolone (PSL), tacrolimus
In patients with APS and previous pregnancy failure who have received standard therapy, HCQ
Overall, HCQ may help improve pregnancy outcomes in patients who have failed a previous pregnancy and are receiving routine treatment with current APS
References: Takaki Y, Daimon A, Nunode M, Tanaka T, Fujita D, Ohmichi M.